1. Kannel W.B., Gordon T. 1970: The Framingham Study — an epidemiological investigation of cardiovascular disease. Washington D.C., R. V. S. Gort, Printing Office.
2. Bottiger L.E., Carlson L.A. 1973: The Stockholm Prospective Study. 2. Skandia Int. Symposia “Early phases of coronary heart disease”, 158–181. Nordinska Bokhandelns Forlag, Stockholm.
3. Sorlie P.D., Garcia-Palmieri M.R., Costas R., Havlik R.J. 1981: Hematocrit and risk of coronary heart disease: The Puerto Rico Heart Health Program. Amer. Heart Jour. 101, 456–461.
4. Carter C., McGee D., Reed D., Yano K., Stemmermann G. 1983: Hematocrit and the risk of coronary heart disease: The Honolulu Heart Program. Amer. Heart J. 105, 674–679.
5. Burge P.S., Johnson W.S., Prankerd T.A.J. 1975: Morbidity and mortality in pseudopolycythemia. Lancet 1, 1266–1269.